Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid for COVID-19 treatment
NCT04363216Phase 2Unknown
- Sponsor
- Thomas Jefferson University
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ascorbic acid in coronavirus disease 2019 (COVID-19), sponsored by Thomas Jefferson University. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04363216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363216.